ML17305A681
| ML17305A681 | |
| Person / Time | |
|---|---|
| Site: | Northwest Medical Isotopes |
| Issue date: | 11/01/2017 |
| From: | Research and Test Reactors Licensing Projects Branch |
| To: | |
| Helvenston E, NRR/DLP, 415-4067 | |
| Shared Package | |
| ML17305A657 | List: |
| References | |
| Download: ML17305A681 (2) | |
Text
DECOMMISSIONING AND POSSESSION-ONLY LICENSE AMENDMENTS Northwest Medical Isotopes, LLC (NWMI or the applicant) preliminary safety analysis report (PSAR) Chapter 17.0, Decommissioning and Possession-Only License Amendments, states that decommissioning information is not required for a construction permit application. As such, the NWMI PSAR does not include a decommissioning plan or report.
The U.S. Nuclear Regulatory Commission (NRC) staff (the staff) evaluated this PSAR chapter and finds that Title 10 of the Code of Federal Regulations (10 CFR) Section 50.33, Contents of applications; general information, paragraph (k) requires an applicant for an operating license for a production facility to submit a decommissioning report, but does not require an applicant for a construction permit for a production facility to submit a decommissioning report. Because the NWMI application seeks a construction permit for a production facility, and because NWMI is not seeking a possession-only license amendment, the staff concludes that no decommissioning information needs to be provided in the PSAR or evaluated for the issuance of a construction permit for a production facility under 10 CFR Part 50, Domestic Licensing of Production and Utilization Facilities.